Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer
My-my Huynh et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
The role of cyclin D1 and Ki-67 in the development and prognostication of thin melanoma
Corina Kaufmann et al.
HISTOPATHOLOGY (2020)
An update on the implications of cyclin D1 in melanomas
Lucia Gonzalez-Ruiz et al.
PIGMENT CELL & MELANOMA RESEARCH (2020)
RSK2 protects human breast cancer cells under endoplasmic reticulum stress through activating AMPKα2-mediated autophagy
Lan-Ya Li et al.
ONCOGENE (2020)
WT1-interacting protein inhibits cell proliferation and tumorigenicity in non-small-cell lung cancer via the AKT/FOXO1 axis
Zhiqiang Wu et al.
MOLECULAR ONCOLOGY (2019)
TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1
Zi-Hao Zhou et al.
CELL BIOLOGY INTERNATIONAL (2019)
RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity
Sun-Mi Yoo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
MicroRNA-223 is essential for maintaining functional β-cell mass during diabetes through inhibiting both FOXO1 and SOX6 pathways
Yutian Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAFV600E mutation bearing metastatic melanoma cells
Evan L. Carpenter et al.
MOLECULAR CARCINOGENESIS (2019)
Circular RNA circCHFR Facilitates the Proliferation and Migration of Vascular Smooth Muscle via miR-370/FOXO1/Cyclin D1 Pathway
Lei Yang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
CX-F9, a novel RSK2 inhibitor, suppresses cutaneous melanoma cells proliferation and metastasis through regulating autophagy
Xu Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2019)
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells
Anna Laurenzana et al.
EBIOMEDICINE (2019)
β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer
Jia Ma et al.
CELL DEATH AND DIFFERENTIATION (2018)
Tenascin-C Modulates Cell Cycle Progression to Enhance Tumour Cell Proliferation through AKT/FOXO1 Signalling in Pancreatic Cancer
Jun Cai et al.
JOURNAL OF CANCER (2018)
p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis
Nicholas Theodosakis et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase
Corinna Kosnopfel et al.
ONCOTARGET (2017)
An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAFV600E inhibitor-resistant metastatic melanoma cells
Shaun Martin et al.
AUTOPHAGY (2017)
Vemurafenib pharmacokinetics and its correlation with efficacy and safety in outpatients with advanced BRAF-mutated melanoma
N. Kramkimel et al.
TARGETED ONCOLOGY (2016)
Cyclin D1, cancer progression, and opportunities in cancer treatment
Shuo Qie et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer
Xiao Peng Mao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
Jenny E. Hernandez-Davies et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Co-targeting BRAF and cyclin dependent kinases 4/6 for BRAF mutant cancers
Vipin Yadav et al.
PHARMACOLOGY & THERAPEUTICS (2015)
RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2
Yuan Xiao Zhu et al.
BLOOD (2015)
Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present
Mathew C. Casimiro et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
The CDK4/6 Inhibitor LY2835219 Overcomes Vemurafenib Resistance Resulting from MAPK Reactivation and Cyclin D1 Upregulation
Vipin Yadav et al.
MOLECULAR CANCER THERAPEUTICS (2014)
MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
Nikhil Wagle et al.
CANCER DISCOVERY (2014)
Insulin induces drug resistance in melanoma through activation of the PI3K/Akt pathway
Mengna Chi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Matthew Holderfield et al.
NATURE REVIEWS CANCER (2014)
Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
Mee-Hyun Lee et al.
CANCER PREVENTION RESEARCH (2013)
RSK Isoforms in Cancer Cell Invasion and Metastasis
Florian J. Sulzmaier et al.
CANCER RESEARCH (2013)
The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin
Marijn T. M. van Jaarsveld et al.
EUROPEAN JOURNAL OF CANCER (2013)
RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth
Y. Romeo et al.
ONCOGENE (2013)
RSK2 as a key regulator in human skin cancer
Yong-Yeon Cho et al.
CARCINOGENESIS (2012)
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Targeting RSK2 in human malignancies
Sumin Kang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Regulation of cyclin D1 gene expression
Ini-Isabee Witzel et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Georgia Hatzivassiliou et al.
NATURE (2010)
Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation
Ramin Nazarian et al.
NATURE (2010)
Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation
Bin Zheng et al.
MOLECULAR CELL (2009)
Codependent functions of RSK2 and the apoptosis-promoting factor TIA-1 in stress granule assembly and cell survival
T. S. Karin Eisinger-Mathason et al.
MOLECULAR CELL (2008)
Arginine Methylation of FOXO Transcription Factors Inhibits Their Phosphorylation by Akt
Kazuyuki Yamagata et al.
MOLECULAR CELL (2008)
Share Paper
